Regional CAR T cell therapy: An ignition key for systemic immunity in solid tumors

Area of Science:

• Immunotherapy
• Oncology
• Cellular Therapy

Background:

• Chimeric antigen receptor (CAR) T-cell therapy shows success in hematologic cancers but faces challenges in solid tumors.
• Key limitations in solid tumors include poor T-cell infiltration and T-cell dysfunction/exhaustion.

Purpose of the Study:

• To evaluate the safety and efficacy of regional delivery of CAR T-cells in solid tumors.
• To assess the impact of regional delivery on T-cell infiltration, proliferation, trafficking, and immune persistence.

Main Methods:

• Clinical assessment of regional CAR T-cell delivery in patients with solid tumors.
• Evaluation of T-cell infiltration, proliferation, and trafficking within the tumor microenvironment.
• Monitoring of systemic immune responses and T-cell persistence post-delivery.

Main Results:

• Regional delivery of CAR T-cells was demonstrated to be safe and feasible in patients with solid tumors.
• The approach significantly improved T-cell infiltration, proliferation, and trafficking into the tumor.
• Regional delivery initiated a functionally persistent systemic anti-tumor immune response.

Conclusions:

• Regional delivery represents a viable strategy to overcome T-cell-related barriers in solid tumor immunotherapy.
• This method enhances CAR T-cell efficacy by promoting local tumor control and durable systemic immunity.